Myriad Genetics Inc.
Salt Lake City, UT
- UEI
- DGD1LL6KYLC8
- CAGE
- 1G6S8
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 621511 Medical Laboratories Primary
- Corporate family
-
-
Myriad Genetics Inc.
DGD1LL6KYLC8
- Assurex Health, Inc. NABWBD5Q6CU9
- Crescendo Bioscience, Inc. KJ1FJFKF1PM9
- Myriad Genetic Laboratories Inc. H7C7T3D6ZSB8
- Myriad Rbm, Inc. KJ9RNTDFC3D1
-
Myriad Genetics Inc.
DGD1LL6KYLC8
- SAM.gov registration date
- Physical address
- 322 N 2200 W, Salt Lake City, UT 84116, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Prolaris testing | Veterans Integrated Service Network 22 | $17,493 | |
| Prolaris testing | Veterans Integrated Service Network 22 | $154,938 | |
| Prolaris testing | Veterans Integrated Service Network 22 | $132,456 | |
| Cancer testing | Veterans Integrated Service Network 4 | $3,900 | |
| Prolaris test results for biopsies sent to lab | Veterans Integrated Service Network 12 | $5,984 |
About Myriad Genetics Inc.
Myriad Genetics Inc. is a molecular diagnostic company headquartered in Salt Lake City, Utah, specializing in genetic testing services for cancer risk assessment, treatment guidance, and disease management. Registered in the System for Award Management (SAM) since August 2, 2000, the company is a for-profit corporate entity with an active federal contract vehicle. As a parent organization with subsidiaries like Myriad Genetic Laboratories Inc., the company focuses on advanced genetic testing technologies that provide clinically actionable insights for healthcare providers and patients.
The federal contract awards demonstrate Myriad Genetics Inc.'s primary focus on providing specialized genetic testing services, predominantly to the Department of Veterans Affairs (VA) across multiple Veterans Integrated Service Networks (VISN). The majority of their contracts involve ProLaris testing, a molecular diagnostic service for prostate cancer that measures gene expression to assess cancer aggressiveness and guide treatment strategies. Contract values have ranged from $3,900 to $589,712, with performance periods typically spanning one to two years. The company has consistently been awarded firm-fixed-price contracts and purchase orders, primarily through the VA healthcare system, with additional minimal engagement with the Defense Health Agency. No set-aside designations were used in these contract awards, indicating open competition. The testing services cover various medical domains, including prostate cancer diagnostics, rheumatoid arthritis disease activity testing, and broader genetic testing capabilities, demonstrating the company's versatility in providing molecular diagnostic solutions to federal healthcare providers.
Quick answers
What is Myriad Genetics Inc.'s UEI?
Myriad Genetics Inc.'s Unique Entity ID (UEI) in SAM.gov is DGD1LL6KYLC8.
What is Myriad Genetics Inc.'s CAGE code?
Myriad Genetics Inc.'s CAGE code is 1G6S8.
What is Myriad Genetics Inc.'s primary NAICS code?
Myriad Genetics Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Myriad Genetics Inc. located?
Myriad Genetics Inc.'s physical address in SAM.gov is 322 N 2200 W, Salt Lake City, UT 84116, USA.
Is Myriad Genetics Inc. registered in SAM.gov?
Yes. Myriad Genetics Inc.'s SAM.gov registration is active through March 27, 2027.
What is Myriad Genetics Inc.'s most recent federal award?
Myriad Genetics Inc.'s most recent federal contract award is Prolaris testing (36C26225C0008), from Veterans Integrated Service Network 22, on October 1, 2024.
On GovTribe
See Myriad Genetics Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors